Award

NU1433-10 RAR-M Therapeutics Ltd The Provision of Business Consultancy to Assist Commercialisation of University Research.

NEWCASTLE UNIVERSITY

This public procurement record has 1 release in its history.

Award

19 May 2020 at 09:28

Award Notice
Summary of the contracting process

The procurement process titled "NU1433-10 RAR-M Therapeutics Ltd The Provision of Business Consultancy to Assist Commercialisation of University Research" is being conducted by Newcastle University in the United Kingdom. This contract, classified under business and management consultancy services, has a value of £30,000 and is currently in the awarded stage. The contract period begins on 1st May 2020 and concludes on 31st December 2020. The tender was initially due to close on 14th April 2020.

This tender presents significant growth opportunities for small and medium-sized enterprises (SMEs) with expertise in business consultancy, particularly those with experience in the pharmaceutical or biotechnology sectors. Companies that have a track record in commercialising research and developing market-leading drugs for neurodegenerative diseases would be particularly well-suited to compete. The opportunity to support Newcastle University's initiative could lead to further collaborations and investments in this evolving healthcare field.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Start Free Trial Book a Demo
All Features Pricing

Notice Information

Notice Title

NU1433-10 RAR-M Therapeutics Ltd The Provision of Business Consultancy to Assist Commercialisation of University Research.

Notice Description

Amyotrophic lateral sclerosis (ALS) - as with most other neurodegenerative diseases, including Alzheimer's and Parkinson's - is a major medical challenge and is having an ever-increasing impact upon the lives of patients, carers and indeed of society as a whole. Scientists at Durham (Chemistry Department) and Aberdeen Universities have recently designed, synthesised and identified a lead drug candidate with the potential for establishing a new treatment approach for ALS and with a longer-term potential of being effective for other neurodegenerative diseases. The technology is now being patented and we are ready to develop a commercial vehicle to drive the drug development programme forwards and raise the necessary investment required for the next stages. The need for an experienced Business Executive/CEO, who has already delivered drugs to the market in the neurodegenerative area, is essential to support the Commercial Team and especially the CEO directly. Although two of the Team have commercial (spinout) experience (e.g. as CTO of LightOx who are successfully raising second phase major investment currently for LightOx), the successful launch of market leading drugs and the raising of the finance to make that happen is needed to successfully take the company forward. In the longer term (such as Phase III raise of ca. PS100+ million), such an executive might well be appointed as CEO, but in these early development stages, advise and business support is required

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-3ba029fa-773a-4d18-8bfe-37f9fa03f5cd
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/910dc1b3-d759-4de4-8eb8-0f9775e29dcc
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Standard
Procurement Category
Services
Procurement Method
Not Specified
Procurement Method Details
Other -
Tender Suitability
SME
Awardee Scale
SME

Common Procurement Vocabulary (CPV)

CPV Divisions

79 - Business services: law, marketing, consulting, recruitment, printing and security

CPV Codes

79400000 - Business and management consultancy and related services

Notice Value(s)

Tender Value
£30,000 Under £100K
Lots Value
Not specified
Awards Value
£30,000 Under £100K
Contracts Value
Not specified

Notice Dates

Publication Date
19 May 20205 years ago
Submission Deadline
14 Apr 2020Expired
Future Notice Date
Not specified
Award Date
21 Apr 20205 years ago
Contract Period
30 Apr 2020 - 31 Dec 2020 6-12 months
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Not Specified
Awards Status
Active
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NEWCASTLE UNIVERSITY
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
NEWCASTLE
Postcode
NE1 7RU
Post Town
Newcastle upon Tyne
Country
England
Major Region (ITL 1)
TLC North East (England)
Basic Region (ITL 2)
TLC4 Northumberland, Durham and Tyne & Wear
Small Region (ITL 3)
TLC43 Tyneside
Delivery Location
TLC North East (England), TLD North West (England), TLF East Midlands (England), TLG West Midlands (England), TLH East (England), TLJ South East (England), TLK South West (England)
Local Authority
Newcastle upon Tyne
Electoral Ward
Monument
Westminster Constituency
Newcastle upon Tyne Central and West

Supplier Information

Number of Suppliers
1
Supplier Name

DYODELTA BIOSCIENCES

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts. 

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-b5fd17-3ba029fa-773a-4d18-8bfe-37f9fa03f5cd-2020-05-19T10:28:51+01:00",
    "date": "2020-05-19T10:28:51+01:00",
    "ocid": "ocds-b5fd17-3ba029fa-773a-4d18-8bfe-37f9fa03f5cd",
    "language": "en",
    "initiationType": "tender",
    "tender": {
        "id": "NCL001-DN473477-33950644",
        "title": "NU1433-10 RAR-M Therapeutics Ltd The Provision of Business Consultancy to Assist Commercialisation of University Research.",
        "description": "Amyotrophic lateral sclerosis (ALS) - as with most other neurodegenerative diseases, including Alzheimer's and Parkinson's - is a major medical challenge and is having an ever-increasing impact upon the lives of patients, carers and indeed of society as a whole. Scientists at Durham (Chemistry Department) and Aberdeen Universities have recently designed, synthesised and identified a lead drug candidate with the potential for establishing a new treatment approach for ALS and with a longer-term potential of being effective for other neurodegenerative diseases. The technology is now being patented and we are ready to develop a commercial vehicle to drive the drug development programme forwards and raise the necessary investment required for the next stages. The need for an experienced Business Executive/CEO, who has already delivered drugs to the market in the neurodegenerative area, is essential to support the Commercial Team and especially the CEO directly. Although two of the Team have commercial (spinout) experience (e.g. as CTO of LightOx who are successfully raising second phase major investment currently for LightOx), the successful launch of market leading drugs and the raising of the finance to make that happen is needed to successfully take the company forward. In the longer term (such as Phase III raise of ca. PS100+ million), such an executive might well be appointed as CEO, but in these early development stages, advise and business support is required",
        "status": "complete",
        "classification": {
            "scheme": "CPV",
            "id": "79400000",
            "description": "Business and management consultancy and related services"
        },
        "items": [
            {
                "id": "1",
                "deliveryAddresses": [
                    {
                        "region": "England",
                        "countryName": "United Kingdom"
                    }
                ]
            }
        ],
        "value": {
            "amount": 30000,
            "currency": "GBP"
        },
        "procurementMethodDetails": "Other -",
        "tenderPeriod": {
            "endDate": "2020-04-14T23:59:59+01:00"
        },
        "contractPeriod": {
            "startDate": "2020-05-01T00:00:00+01:00",
            "endDate": "2020-12-31T23:59:59Z"
        },
        "suitability": {
            "sme": true,
            "vcse": false
        },
        "mainProcurementCategory": "services"
    },
    "parties": [
        {
            "id": "GB-CFS-51687",
            "name": "Newcastle University",
            "identifier": {
                "legalName": "Newcastle University"
            },
            "address": {
                "streetAddress": "Newcastle University, Procurement Services, Kingsgate",
                "locality": "Newcastle",
                "postalCode": "NE1 7RU",
                "countryName": "England"
            },
            "contactPoint": {
                "name": "Natalie Morton",
                "email": "natalie.morton@ncl.ac.uk",
                "telephone": "+44 1912086396"
            },
            "roles": [
                "buyer"
            ]
        },
        {
            "id": "GB-CFS-143932",
            "name": "DyoDelta Biosciences Ltd",
            "identifier": {
                "legalName": "DyoDelta Biosciences Ltd"
            },
            "address": {
                "streetAddress": "22a St. James's Square London Greater London SW1Y 4JH"
            },
            "details": {
                "scale": "sme",
                "vcse": false
            },
            "roles": [
                "supplier"
            ]
        }
    ],
    "buyer": {
        "id": "GB-CFS-51687",
        "name": "Newcastle University"
    },
    "awards": [
        {
            "id": "ocds-b5fd17-3ba029fa-773a-4d18-8bfe-37f9fa03f5cd-1",
            "status": "active",
            "date": "2020-04-22T00:00:00+01:00",
            "datePublished": "2020-05-19T10:28:51+01:00",
            "value": {
                "amount": 30000,
                "currency": "GBP"
            },
            "suppliers": [
                {
                    "id": "GB-CFS-143932",
                    "name": "DyoDelta Biosciences Ltd"
                }
            ],
            "contractPeriod": {
                "startDate": "2020-05-01T00:00:00+01:00",
                "endDate": "2020-12-31T23:59:59Z"
            },
            "documents": [
                {
                    "id": "1",
                    "documentType": "awardNotice",
                    "description": "Awarded contract notice on Contracts Finder",
                    "url": "https://www.contractsfinder.service.gov.uk/Notice/910dc1b3-d759-4de4-8eb8-0f9775e29dcc",
                    "datePublished": "2020-05-19T10:28:51+01:00",
                    "format": "text/html",
                    "language": "en"
                }
            ]
        }
    ]
}